SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

OTLK

Outlook Therapeutics Inc.
NASDAQHealth Care

Latest close: 0.49 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 30, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 18, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 27, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record76424 flagged findings
Reported transactions (Form 4)62since Jan 17, 2023
Corporate events (8-K)30since Dec 6, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-04-23share offering or dilution eventrecentOpen filing ↗
    “…a related prospectus and prospectus supplement thereunder, and (ii) in a concurrent private placement (the “Private Placement” and…”
    +1 more passage from the same document
    • “…warrants to purchase an aggregate of 16,129,033 shares of Common Stock (the “Common Warrants”). The combined purchase price of…”
  • 2026-04-23share offering or dilution eventrecentOpen filing ↗
    “…4(a)(2) of the Securities Act and Regulation D promulgated thereunder. The common warrants are not and will not be listed for…”
    +1 more passage from the same document
    • “…stock for each share of common stock sold. The common stock and the common warrants sold in the concurrent private placement are…”
  • 2026-04-23listing compliance noticerecentOpen filing ↗
    “…the bid price of our common stock had closed below $1.00 per share, the minimum closing bid price required by the continued…”
    +1 more passage from the same document
    • “…rules. However, there can be no assurance that, if we do appeal the delisting determination by Nasdaq to the panel, such appeal…”
  • 2026-04-23capital return (buybacks/dividends)recentOpen filing ↗
    “…Debt Securities Warrants From time to time, we may offer up to $300,000,000 of any combination of shares of our common stock, shares…”
    +1 more passage from the same document
    • “…· the dividend rate, period and payment date, and method of calculation for dividends; · whether dividends will be cumulative or…”
  • 2026-03-25share offering or dilution eventrecentOpen filing ↗
    “…of the Company's outstanding Common Stock immediately after exercise, which percentage may be changed at the holder's…”
    +1 more passage from the same document
    • “…the Offering. In the Offering, the Company agreed to issue and sell (i) 20,000,000 shares of the Company's common stock, par value…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Sep 30, 2026).

Deadline: Mar 24, 2027

  • minimum bid price · Nasdaq, rule 5550(a)(2) · notice of Sep 25, 2026 · pending · deadline Mar 24, 2027 (text and rule agree)

The other times

Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.

Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.

Open the 8-K at the SEC

Reverse splits in 5 years

1 reverse split in 5 years (1:20 on Mar 14, 2024) · 1:20 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 764)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 13, 26SCHEDULE 13G ↗Passive stake · Empery Asset Management, LP · 8.7% · event on Sep 30, 26 new
  • Sep 30, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Sep 18, 268-K ↗Current report · Other events
  • Sep 2, 26Form 4 ↗Insider transaction
  • Sep 2, 26Form 3 ↗Insider transaction
  • Aug 27, 268-K ↗Current report · A senior executive left or was appointed
  • Aug 19, 26SCHEDULE 13G ↗Passive stake · CVI Investments, Inc. · 9.9% · event on Aug 12, 26
  • Aug 18, 2610-Q ↗Quarterly report
  • Aug 17, 26NT 10-Q ↗Late filing notice
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 14, 268-K ↗Current report · Other events
  • Aug 14, 26424B5 ↗Securities offering
  • Aug 14, 268-K ↗Current report · Results
  • Aug 14, 26SCHEDULE 13D/A ↗Stake with intent to influence · GMS Ventures & Investments · 16.4% · event on Aug 12, 26 · amendment
  • Aug 14, 26Form 4 ↗Insider transaction
  • Aug 12, 26424B5 ↗Securities offering
  • Aug 12, 268-K ↗Current report · Results · Other events
  • Jul 29, 26Form 4 ↗Insider transaction
  • Jul 24, 268-K ↗Current report · Other events
  • Jul 24, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jul 21, 26424B3 ↗Securities offering
  • Jul 17, 26S-3 ↗Securities offering

764 filings on record, the oldest from Dec 14, 15.

Listing the 25 most recent filings of the 764 on record.

8-Ks, explained

Stress14Structure79Governance39
  • Sep 30, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Aug 27, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 24, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 26, 26StressListing notice (8-K 3.01)the same filing reports the recovery8-K 3.01 ↗
  • May 13, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 23, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Mar 16, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 11, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Feb 18, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Governance3 senior executive changes2025show all 3hide
    • Sep 5, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jul 1, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 11, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Mar 14, 25StructureA material agreement was terminated+3 more in the same filing8-K 1.02 ↗
  • Jan 31, 25StructureSold unregistered shares+4 more in the same filing8-K 3.02 ↗

8 older filings not shown · The record reaches back to May 19, 16.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Dec 16, 24StressRestructuring plan with committed costs8-K 2.05 ↗
  • Oct 20, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 9, 20StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 2, 20StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Dec 23, 19StressListing notice (8-K 3.01)+6 more in the same filing8-K 3.01 ↗
  • Jun 14, 19StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Oct 30, 18StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 14 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • GMS Ventures & Investments16.4%Aug 12, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • CVI Investments, Inc.9.9%Aug 12, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Empery Asset Management, LP8.7%Sep 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Mitchell P. Kopin5.0%Apr 22, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Great Point Partners, LLC5.0%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Sphera Funds Management Ltd.4.7%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
show one more holderhide
  • TANG CAPITAL MANAGEMENT, LLC3.4%Jun 30, 25SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 14, 26Buyamount n/aRobert Charles JahrChief Executive Officer↗
  • Aug 14, 26Buyamount n/aLAWRENCE A KENYONChief Financial Officer↗
  • Aug 12, 26Buy$2.5MGhiath M. Sukhtian↗
  • Jul 29, 26Buy$100KFaisal Ghiath Sukhtian↗
  • Jun 2, 26Buy$24KYezan Munther Haddadin↗
  • May 28, 26Buy$5.0MGhiath M. Sukhtian↗
  • May 27, 26Buy$50KFaisal Ghiath Sukhtian↗
  • May 26, 26Buy$177KKURT J HILZINGER↗
  • May 26, 26Buy$2KRANDY H THURMAN↗
  • May 26, 26Buy$15KYezan Munther Haddadin↗
  • Sep 26, 24Buy$28KLAWRENCE A KENYONChief Financial Officer↗
  • Apr 15, 24Buyamount n/aSyntone Ventures LLC↗

There are 7 more transactions in this stretch.

Stock compensation, tax and giftsshow the 3 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • May 27, 25Compensation$6.0MGhiath M. Sukhtian↗
  • Jan 17, 25Compensation$8.7MGhiath M. Sukhtian↗
  • Mar 18, 24Compensationamount n/aGhiath M. Sukhtian↗

The full record holds 22 transactions and goes back to Jan 17, 23.

Its sector and its market

Outlook Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Outlook Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Outlook Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
764 documents on file, from Dec 14, 2015 to Oct 13, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.